One potential mechanism underlying chemoresistance to 5-FU and oxaliplatin is the ability of Fn to target innate immune signaling pathways such as Toll-like receptor 4 (TLR4) and activating Myeloid differentiation primary response 88 (MyD88) in cancer cells to activate autophagy pathway11. Here, TLR4 is linked to cancer.